AUM $645.8MER 0.96%NAV $303.96Holdings 156Inception May 2015
Price Chart
Key Statistics
Previous Close
$335.54Day Range
$320.25$331.28
52-Week Range
$69.33$341.55
Avg Volume
455.3KDividend Yield
0.79%Expense Ratio
0.96%AUM
$645.8MShares Outstanding
5.3METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 99.60% |
| Financial Services | 0.40% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 98.83% |
| United Kingdom | 1.27% |
| Ireland | 1.22% |
| Netherlands | 1.10% |
| Switzerland | 1.04% |
Fund Information
- Issuer
- Direxion
- Category
- Healthcare
- Inception Date
- May 28, 2015
- Exchange
- NYSE_ARCA
- Description
- The Direxion Daily S&P Biotech Bull and Bear 3X ETFs seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.
Similar ETFs
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund issued by Direxion that launched on May 28, 2015. It currently manages $645.8M in assets under management. The fund charges an expense ratio of 0.96%. The fund holds 156 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 82.4% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | — | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 71.04% | 131,242 | $1.74B |
| 2 | — | GOLDMAN FINL SQ TRSRY INST 506 | 5.04% | 123,505,151 | $123.5M |
| 3 | — | DREYFUS GOVT CASH MAN INS | 3.56% | 87,209,369 | $87.2M |
| 4 | MRNA | MODERNA INC | 0.66% | 93,262 | $16.3M |
| 5 | — | GOLDMAN SACHS FIN GOV 465 INSTITUT | 0.55% | 13,367,640 | $13.4M |
| 6 | TWST | TWIST BIOSCIENCE CORP | 0.37% | 63,289 | $9.0M |
| 7 | ORKA | ORUKA THERAPEUTICS INC | 0.30% | 66,986 | $7.3M |
| 8 | APGE | APOGEE THERAPEUTICS INC | 0.28% | 51,851 | $7.0M |
| 9 | KYMR | KYMERA THERAPEUTICS INC | 0.28% | 54,827 | $7.0M |
| 10 | PRAX | PRAXIS PRECISION MEDICINES I | 0.28% | 17,822 | $6.9M |
| 11 | HALO | HALOZYME THERAPEUTICS INC | 0.27% | 60,838 | $6.5M |
| 12 | NTRA | NATERA INC | 0.26% | 19,811 | $6.4M |
| 13 | RVMD | REVOLUTION MEDICINES INC | 0.26% | 29,746 | $6.4M |
| 14 | DNTH | DIANTHUS THERAPEUTICS INC | 0.26% | 56,125 | $6.4M |
| 15 | CGON | CG ONCOLOGY INC | 0.26% | 78,097 | $6.3M |
Page 1 of 4
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -2.18% | |
| 1W | +13.19% | |
| 1M | +33.28% | |
| 3M | +71.25% | |
| 6M | +90.05% | |
| YTD | +108.40% | |
| 1Y | +373.42% | |
| 3Y | +235.61% | |
| 5Y | -74.74% |
Moving Averages
20-Day MA
$278.19
Above 20-Day MA50-Day MA
$268.50
Above 50-Day MA200-Day MA
$192.47
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$341.55
Current Price
$328.22
52-Week Low
$69.33
$69.33$341.55
Current Yield
0.79%
Annual Dividend
$1.3385
Frequency
4x/year
Last Ex-Date
Dec 23, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 23, 2025 | $0.9097 | Dec 31, 2025 |
| Sep 23, 2025 | $0.1027 | Sep 30, 2025 |
| Jun 24, 2025 | $0.2190 | Jul 1, 2025 |
| Mar 25, 2025 | $0.1071 | Apr 1, 2025 |
| Jun 25, 2024 | $0.1502 | Jul 2, 2024 |
| Mar 19, 2024 | $0.1606 | Mar 26, 2024 |
| Dec 21, 2023 | $0.2097 | Dec 29, 2023 |
| Sep 19, 2023 | $0.0020 | Sep 26, 2023 |
| Sep 19, 2023 | $0.0020 | Sep 26, 2023 |
| Jun 21, 2023 | $0.0090 | Jun 28, 2023 |
| Jun 21, 2023 | $0.0087 | Jun 28, 2023 |
| Dec 23, 2019 | $0.0053 | Dec 31, 2019 |
| Dec 23, 2019 | $0.0050 | Dec 31, 2019 |
| Sep 24, 2019 | $0.0110 | Oct 1, 2019 |
| Sep 24, 2019 | $0.0108 | Oct 1, 2019 |
| Jun 25, 2019 | $0.0374 | Jul 2, 2019 |
| Jun 25, 2019 | $0.0370 | Jul 2, 2019 |
| Mar 19, 2019 | $0.1100 | Mar 26, 2019 |
| Mar 19, 2019 | $0.1097 | Mar 26, 2019 |
| Dec 27, 2018 | $0.0962 | Jan 4, 2019 |
Dividend Payments Over Time
Category Comparison
| Metric | LABU | Healthcare(223 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.96% | 0.62% | 0.84% |
| AUM | $645.8M | $1.98B | $1.86B |
| Dividend Yield | 0.79% | 3.90% | 1.97% |
| Avg Volume | 455.3K | 422.1K | 1.1M |
| Holdings | 156 | 167 | 65 |
| Performance | |||
| 1-Month Return | +47.55% | +6.56% | +11.19% |
| 6-Month Return | +84.14% | +16.09% | +26.77% |
| YTD Return | +110.52% | +16.75% | +27.34% |
| 1-Year Return | +102.08% | +15.10% | +23.91% |
Compare with Another ETF
Search for an ETF to compare with LABU:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.